Search

Abstract: Electrospun blended nanofibrous scaffolds were fabricated from an synthetic biodegradable polymer (poly(ethylene carbonate-ɛ-caprolactone) (poly(EC-CL)) and vascular endothelial growth factor with different weight ratios. Results showed that the diameter of blended scaffolds was 440±55nm. VEGF on the surface of the blended scaffolds was identified by immunofluorescence. In vitro cell proliferation, viability assay results showed that human umbilical vein endothelial cells (HUVECs) had a good growth and spread morphology on the blended scaffolds. Scaffolds electrospun from this polymer contained VEGF had a good application in tissue engineering. [Copyright &y& Elsevier]

Abstract: The use of current drug-loaded vascular scaffolds is limited in sustained drug release and stability studies in clinical and preclinical trials. We found that poly(l-glutamic acid)-b-poly(propylene oxide)-b-poly(l-glutamic acid) (PLGA-b-PPO-b-PLGA) triblock copolymers can deliver multiple poorly water-soluble drugs (e.g., Paclitaxel) at clinically relevant doses. In this study, we synthesized a new drug-loaded vascular external graft with electrospun nanofibrous scaffolds [poly(l-lactide-co-ɛ-caprolactone) (PLCL):fibrinogen; 2:1 (w/w)] and drug-loaded PLGA-b-PPO-b-PLGA micelles. Cell proliferation and viability assay results showed that beagle smooth muscle cells grew well on the surface of vascular graft-coated micelles at a percentages of 10% (w/w) GPG:PLCL–fibrinogen. This study demonstrates that micelle-coated electrospun PLCL–fibrinogen vascular scaffolds have potential applications in vascular tissue engineering. [Copyright &y& Elsevier]